‘Like a Coin Flip’: Assay Denies Some Cancer Patients New Drug
The test that determines the eligibility of breast cancer patients to receive atezolizumab is like flipping a coin in terms of accuracy, says a critic. The manufacturer, Roche, says it is effective. Medscape Medical News …read more